Lilly's Basaglar, Crestor Generics Helped Hold Down Drug Spending Growth In 2017
Executive Summary
Express Scripts' annual drug trend report highlights impact of key follow-on launches, and its own management solutions programs, in limiting the growth in overall drug spending for commercial plans to 1.5%; forecast calls for double-digit growth in inflammatory category to continue at least the next three years until biosimilar savings kick in.